These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 6819816)

  • 1. DMBA-induced tumors and their prevention by aromatic retinoid (Ro 10-9359).
    Mahrle G; Berger H
    Arch Dermatol Res; 1982; 272(1-2):37-47. PubMed ID: 6819816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Experimental keratocanthoma [author's transl]].
    Harms M; Olmos L; Hunziker N; Laugier P
    Arch Dermatol Res (1975); 1976 Dec; 257(2):131-42. PubMed ID: 827243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antitumor effect of retinoids (author's transl)].
    Mahrle G; Berger H
    Z Hautkr; 1982 Mar; 57(6):429-33. PubMed ID: 7080592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Tumor prevention in xeroderma pigmentosum using aromatic retinoid (Ro 10-9359)].
    Braun-Falco O; Galosi A; Dorn M; Plewig G
    Hautarzt; 1982 Aug; 33(8):445-8. PubMed ID: 7141872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Tumors of the mouse submandibular gland induced by 7, 12-DMBA. A histopathological observation (author's transl)].
    Kawahara K; Kumagai K; Nikai H
    Hiroshima Daigaku Shigaku Zasshi; 1979; 11(1):115-24. PubMed ID: 121305
    [No Abstract]   [Full Text] [Related]  

  • 6. Demonstration of gap junctions by lanthanum in the vitamin A acid-treated skin tumor, keratoacanthoma.
    Prutkin L
    Experientia; 1975 Nov; 31(11):1346-8. PubMed ID: 812730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinogen-induced cutaneous neoplasms in nonhuman primates.
    Palotay JL; Adachi K; Dobson RL; Pinto JS
    J Natl Cancer Inst; 1976 Dec; 57(6):1269-74. PubMed ID: 826652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the promotion phase in two-step carcinogenesis in forestomach epithelium of mice by the aromatic retinoid etretinate.
    Wagner G; Habs M; Schmähl D
    Arzneimittelforschung; 1983; 33(6):851-2. PubMed ID: 6412724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nature of skin fragility in patients receiving retinoids for systemic effect.
    Williams ML; Elias PM
    Arch Dermatol; 1981 Oct; 117(10):611-9. PubMed ID: 6945067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of the effect of vitamin A acid on the skin tumor keratoacanthoma by applications of actinomcin D.
    Prutkin L
    Cancer Res; 1971 Aug; 31(8):1080-6. PubMed ID: 4328822
    [No Abstract]   [Full Text] [Related]  

  • 11. An ultrastructure study of the experimental keratoacanthoma.
    Prutkin L
    J Invest Dermatol; 1967 Apr; 48(4):326-36. PubMed ID: 6022600
    [No Abstract]   [Full Text] [Related]  

  • 12. An ultrastructural study of the localization of acid phosphatase activity in the untreated and vitamin A acid treated keratoacanthoma.
    Prutkin L; Bogart B
    J Invest Dermatol; 1970 Feb; 54(2):126-31. PubMed ID: 5412728
    [No Abstract]   [Full Text] [Related]  

  • 13. [The stimulation of dopaoxidase-positive melanocytes during skin carcinogenesis].
    Rohrbach R
    Virchows Arch B Cell Pathol; 1969; 3(2):219-28. PubMed ID: 4185227
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibition of 7-bromomethylbenz[a]anthracene-promoted mouse skin tumor formation by retinoic acid and dexamethasone.
    Verma AK; Garcia CT; Ashendel CL; Boutwell RK
    Cancer Res; 1983 Jul; 43(7):3045-9. PubMed ID: 6406052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RESISTANCE AGAINST CARCINOMAS OF THE SKIN INDUCED BY DIMETHYLBENZANTHRACENE (DMBA) IN MICE OF THE STRAIN XVII BLN.
    PASTERNAK G; GRAFFI A; HOFFMANN F; HORN KH
    Nature; 1964 Jul; 203():307-8. PubMed ID: 14201775
    [No Abstract]   [Full Text] [Related]  

  • 16. The development of malignant tumours of mouse skin after initiating and promoting stimuli. IV. Comparison of the effects of single and divided initiating doses of 9, 10-dimethyl-1, 2-benzanthracene (DMBA).
    SALAMAN MH; ROE FJ
    Br J Cancer; 1956 Mar; 10(1):79-88. PubMed ID: 13342325
    [No Abstract]   [Full Text] [Related]  

  • 17. Non-immunological regression of dimethylbenz(A) anthracene-induced experimental keratoacanthomas in the rabbit.
    Ramselaar CG; van der Meer JB
    Dermatologica; 1979; 158(2):142-51. PubMed ID: 104893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [TUMORS OF THE SKIN IN RATS INDUCED BY 9,10-DIMETHYL-1,2-BENZANTHRACENE].
    TURUSOV VS
    Arkh Patol; 1964; 26():44-50. PubMed ID: 14182492
    [No Abstract]   [Full Text] [Related]  

  • 19. The development of malignant tumours of mouse skin after initiating and promoting stimuli. I. The effect of a single application of 9, 10-dimethyl-1, 2-benzanthracene (DMBA), with and without subsequent treatment with croton oil.
    ROE FJ
    Br J Cancer; 1956 Mar; 10(1):61-9. PubMed ID: 13342322
    [No Abstract]   [Full Text] [Related]  

  • 20. Mucous metaplasia and gap junctions in the vitamin A acid-treated skin tumor, keratoacanthoma.
    Prutkin L
    Cancer Res; 1975 Feb; 35(2):364-9. PubMed ID: 1109802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.